Epigenomics AG (FRA:ECX)
Germany · Delayed Price · Currency is EUR 1.150
-0.050 (-4.17%)
Aug 12, 2026, 8:01 AM CET
Epigenomics AG Revenue
In the year 2025, Epigenomics AG had annual revenue of 24.00K EUR. Epigenomics AG had revenue of 20.00K in the half year ending December 31, 2025, a decrease of -85.32%.
Revenue
24.00K
Revenue Growth
n/a
P/S Ratio
42.02
Revenue / Employee
8.00K
Employees
3
Market Cap
1.01M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 339.00K | -560.00K | -62.29% |
| Dec 31, 2022 | 899.00K | -5.30M | -85.51% |
| Dec 31, 2021 | 6.20M | 5.36M | 636.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.38B |
| Fresenius SE & Co. KGaA | 23.28B |
| Siemens Healthineers AG | 23.17B |
| Merck KGaA | 21.14B |
| Maternus-Kliniken Aktiengesellschaft | 118.03M |
| Geratherm Medical AG | 15.36M |
| SynBiotic SE | 14.86M |
| Biofrontera AG | 13.63M |